The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology

Steroids

Volumn 62, Issue 1, 1997, Pages 148-158

  Labrie, Fernand ^a   Luu The, Van ^a   Lin, Sheng Xiang ^a   Labrie, Claude ^a   Simard, Jacques ^a   Breton, Roch ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

3 HSDs; androgen; estrogen; intracrinology; regulation; types 1, 2, 3, 4, and 5 17 HSDs

Indexed keywords

HYDROXYSTEROID DEHYDROGENASE;

ANDROGEN SYNTHESIS; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME SPECIFICITY; ESTROGEN SYNTHESIS; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; STEROIDOGENESIS;

MACACA MULATTA; MAMMALIA;

EID: 0031023049     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00174-2     Document Type: Conference Paper

References (74)

1. Labrie F (1991). Intracrinology. Mol Cell Endocrinol 78:C113-C118.
2. Labrie F, Dupont A, Bélanger A (1985). Complete androgen blockade for the treatment of prostate cancer. In: de Vita VT, Hellman S, Rosenberg SA (eds), Important Advances in Oncology. J.B. Lippincott. Philadelphia, pp. 193-217.
3. Hobkirk R (1993). Steroid sulfation: current concepts. Trends Endocr Metab 4:69-74.
4. Stewart PM, Sheppard MC (1992). Novel aspects of hormone action: intracellular ligand supply and its control by a series of tissue-specific enzymes. Mol Cell Endocrinol 83:C13-C18.
5. Roy AK (1992). Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proc Soc Exp Biol Med 199:265-272.
6. Labrie F (1993). Intracrinology: its impact on prostate cancer. Curr Opin Urol 3:381-387.
7. Cutler GB Jr, Glenn M, Bush M (1978). Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 103:2112-2118.
8. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G (1992). Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 43:805-826.
9. Bélanger B, Bélanger A, Labrie F, Dupont A, Cusan L, Monfette G (1989). Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J Steroid Biochem 32:695-698.
10. Labrie F, Dupont A, Simard J, Luu-The V, Bélanger A (1993). Intracrinology: the basis for the rational design of endocrine therapy at all stages of prostate cancer. Eur Urol 24 (Suppl. 2):94-105.
11. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G, Morel Y, Mebarki F, Sanchez R, Durocher F, Turgeon C, Labrie Y, Rhéaume E, Labrie C, Lachance Y (1996). The 3β-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. In: Hansson V, Levy FO, Taskén K (eds), Signal Transduction in Testicular Cells. Ernst Schering Research Foundation Workshop. Springer-Verlag, Berlin, Heidelberg, New York, pp. 185-218.
12. Labrie C, Martel C, Dufour JM, Lévesque C, Mérand Y, Labrie F (1992). Novel compounds inhibit estrogen formation and action. Cancer Res 52:610-615.
13. Luo S, Sourla A, Bélanger A, Gauthier S, Mérand Y, Labrie F. (1996). Effect of 24-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice. Proceedings of the Endocrine Society Meeting, San Francisco, p. 151.
14. Martel C, Gauthier S, Mérand Y, Li S, Provencher L, Labrie F. (1996). Comparison of the effects of the new antiestrogens EM-800 and ICI 182 780 on estrogen-sensitive parameters in the ovariectomized mouse. Proceedings of the Endocrine Society Meeting, San Francisco, p. 151.
15. Labrie F, Leblanc G, Gauthier S, Singh M, Provencher L, Li X, Mérand Y. (1996). Binding characteristics of the pure antiestrogens EM-652 and Em-800 to the human estrogen receptor. Proceedings of the Endocrine Society Meeting, San Francisco, p. 605.
16. Couillard S, Labrie C, Gauthier S, Mérand Y, Labrie F. (1996). Highly potent and pure antiestrogenic activity of a new antiestrogen on human ZR-75-1 breast tumors in nude mice. Proceedings of the Endocrine Society Meeting, San Francisco, p. 604.
17. Labrie C, Bélanger A, Labrie F (1988). Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:1412-1417.
18. 4 isomerase (3β-HSD), 17β-HSD 5α-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 104:103-111.
19. Martel C, Rhéaume E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J, Labrie F (1992). Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity and human tissues. J Steroid Biochem Mol Biol 41:597-603.
20. Bolander FF (1996). Introduction. In: Molecular Endocrinology. Academic Press, San Diego, London, pp. 1-23.
21. Milewich L, Garcia RL, Gerrity L (1985). 17β-Hydroxysteroid oxydoreductase: an ubiquitous enzyme. Interconversion of estrone and estradiol-17β in BALB/c mouse tissues. Metabolism 34:938-944.
22. Weinstein GD, Frost P, Hsia SL (1968). In vitro interconversion of estrone and 17β-estradiol in human skin and vaginal mucosa. J Invest Dermatol 5:4-10.
23. Milewich L, Hendricks TS, Romero LH (1982). Interconversion of estrone and estradiol-17β in lung slices of the adult human. J Steroid Biochem 17:669-674.
24. Breuer H, Knuppen R, Haupt M (1966). Metabolism of oestrone and oestradiol-17β in human liver in vitro. Nature 212:76.
25. Bleau G, Roberts KD, Chapdelaine A (1974). The in vitro and in vivo uptake and metabolism of steroid in human adipose tissue. J Clin Endocrinol Metab 39:236-246.
26. Jacobson GM, Hochberg RB (1968). 17β-Hydroxysteroid dehydrogenase from human red blood cells. J Biol Chem 243:2985-2994.
27. Poulin R, Poirier D, Mérand Y, Thériault C, Bélanger A, Labrie F (1989). Extensive esterification of adrenal C19-Δ5 sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. J Biol Chem 264:9335-9343.
28. Lacoste D, Bélanger A, Labrie F (1990). Biosynthesis and degradation of androgens in human prostatic cancer cell lines. In: Bradlow H, Castagnetta L, d'Aquino S, Labrie F (eds), Steroid Formation, Degradation, and Action in Peripheral, Normal, and Neoplastic Tissue. New York Academy of Sciences, New York, pp. 389-391.
29. Beranek PA, Folkred EJ, Ghilchik MW, James VHT (1984). 17β-hydroxysteroid dehydrogenase and aromatase activity in breast fat from women with benign and malignant breast tumors. Clin. Endocrinol 20:205-212.
30. Ryan KJ, Engel LL (1953). The interconversion of estrone and estradiol by human tissue slices. Endocrinology 52:287-291.
31. Bogovich K, Payne AH (1980). Purification of rat testicular microsomal 17-ketosteroid reductase. Evidence that 17-ketosteroid reductase and 17 beta-hydroxysteroid dehydrogenase are distinct enzymes. J Biol Chem 255:5552-5559.
32. Blomquist CH, Lindemann NJ, Hakanson EY (1987). Steroid modulation of 17β-hydroxysteroid oxidoreductase activities in human placental villi in vitro. J Clin Endocrinol Metab 65:647-652.
33. Lieberman S, Greenfield NJ, Wolfson A (1984). A heuristic proposal for understanding steroidogenic processes. Endocr Rev 5:128-148.
34. Luu-The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R, Labrie F (1989). Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′ termini in human placenta. Mol Endocrinol 3:1301-1309.
35. Peltoketo H, Isomaa V, Mäentausta O, Vihko R (1988). Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239:73-77.
36. Pittaway DE, Andersen RN, Jr SAC, Givens JR, Wiser WL (1983). Human ovarian 17β-hydroxysteroid oxidoreductase activity. A comparison of normal and polycystic ovarian tissues. J Clin Endocrinol Metab 56:715-719.
37. Wu L, Einstein M, Geissler WM, Chan KH, Elliston KO, Andersson S (1993). Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969.
38. Casey ML, MacDonald PC, Andersson S (1994). 17β-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 94:2135-2141.
39. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendoça BB, Elliston KO, Wilson JD, Russel DW, Andersson S (1994). Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genet 7:34-39.
40. Adamski J, Normand T, Iffnders F, Monté D, Begue A, Stehelin D, Jungslut PW, de Launoit Y (1995). Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV. Biochem J 311:437-443.
41. Luu-The V, Labrie C, Simard J, Lachance Y, Zhao HF, Couët J, Leblanc G, Labrie F (1990). Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol Endocrinol 4:268-275.
42. Rommens JA, Durocher F, McArthur J, Tonin P, Leblanc JF, Allen T, Samson C, Ferri L, Narod S, Morgan K, Simard J (1995). Generation of a transcription map of the HSD17B locus centromeric to BRCA1 at 17q21. Genomics 28:530-542.
43. Peltoketo H, Isomaa V, Vihko R (1992). Genomic organization and DNA sequences of human 17β-hydroxysteroid dehydrogenase genes and flanking regions: localization of multiple Alu sequences and putative cis-acting elements. Eur J Biochem 209:459-466.
44. Tremblay Y, Ringler GE, Morel Y, Mohandas TK, Labrie F, Strauss III JF, Miller WL (1989). Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen-q25. J Biol Chem 264:20458-20462.
45. Simard J, Feunteun J, Lenoir G, Tonin P, Normand T, Luu-The V, Vivier A, Lasko D, Morgan K, Rouleau GA, Linch H, Labrie F, Narod S (1993). Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet 2:1193-1199.
46. Dumont M, Luu-The V, De Launoit Y, Labrie F (1992). Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cells. J Steroid Biochem Mol Biol 41:605-608.
47. Lin SX, Yang F, Jin JZ, Breton R, Zhu DW, Luu-The V, Labrie F (1992). Subunit identity of the dimeric 17β-hydroxysteroid dehydrogenase from human placenta. J Biol Chem 267:16182-16187.
48. Persson B, Krook M, Jornvall H (1991) Characteristics of short-chain dehydrogenases and related enzymes. Eur J Biochem 200: 537-543.
49. Ghosh D, Wawrzak Z, Weeks CM, Duax WL, Erman M (1994). The refined three-dimensional structure of 3α,20β-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases. Structure 2:629-640.
50. Baker ME (1991). Genealogy of regulation of human sex and adrenal function, prostaglandin action, snapdragon and petunia aflower colors, antibiotics and nitrogen fixation: functional diversity from two ancestral dehydrogenases. Steroids 56:354-360.
51. Krozowski Z (1992). At the cutting edge. 11β-Hydroxysteroid dehydrogenase and the short chain alcohol dehydrogenase (SCAD) superfamily. Mol Cell Endocrinol 84:C25-C31.
52. Chen Z, Jiang JC, Lin ZG, Lee WR, Maker ME, Chang SH (1993). Site specific mutagenesis of Drosophila alcohol dehydrogenase: evidence for involvement of tyrosine-152 and lysine-156 in catalysis. Biochemistry 32:3342-3346.
53. +-dependent 15-hydroxy-prostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem Biophys Res Commun 176:840-845.
54. Obeid J, White PC (1992). Tyr 179 and Lys 183 are essential for enzymatic activity of 11β-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 188:222-227.
55. Ghosh D, Erman M, Wawrzak Z, Duax WL, Pangborn W (1994). Mechanism of inhibition of 3α-20β-hydroxysteroid dehydrogenase by a licorice-derived steroidal inhibitor. Structure 2:973-980.
56. Ghosh D, Orr JC (1991). Three-dimensional structure of holo-3α,20β-hydroxysteroid dehydrogenase: a member of the short-chain dehydrogenase family. Proc Natl Acad Sci USA 88:10064-10068.
57. Varughese KI, Skinner MM, Whiteley JM, Matthews DA, Xuong NH (1992). Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci USA 89:6080-6084.
58. Ghosh D, Pletnev V, Zhu DW, Wawrzak Z, Duax W, Pangborn W, Labrie F, Lin SX (1995). Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 Å resolution. Structure 3: 503-513.
59. Zhu DW, Azzi Z, Rehse P, Lin SX (1996). The crystallogenesis of a human estradiol dehydrogenase-substrate complex. J Crystal Growth 168:272-276.
60. Azzi A, Rehse P, Zhu DW, Campbell RL, Labrie F, Lin SX (1996). Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol at 2.3 A resolution. Nature Struct Biol (in press).
61. Puranen TJ, Poutanen MH, Peltoketo HE, Vihko PT, Vihko RK (1994). Site-directed mutagenesis of the putative active site of human 17 beta-hydroxysteroid dehydrogenase type 1. Biochem J 304: 289-293.
62. Labrie Y, Durocher F, Lachance Y, Turgeon C, Simard J, Labrie C, Labrie F (1995). The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively spliced messenger RNA species. DNA Cell Biol 14:849-861.
63. Durocher F, Morissette J, Labrie Y, Labrie F, Simard J (1995). Mapping of the HSD17B2 gene encoding type II 17β-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q 24.1-q24.2. Genomics 25:724-726.
64. Risinger J, Berchuck A, Kohler M, Boyd J (1994). Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genet 7: 98-102.
65. Sato T, Saito H, Morita R, Koi S, Lee J, Nakamura Y (1991). Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
66. Kunimi K, Bergerheim U, Larsson I, Ekman P, Collins P (1991). Allelotyping of human prostatic adenocarcinoma. Genomics 11: 530-536.
67. Carter B, Ewing C, Ward S, Treiger B, Aalders T, Schalken J, Epstein J, Isaacs W (1990). Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
68. Agarwal AK, Tusie-Luna MT, Monder C, White PC (1990). Expression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol Endocrinol 4:1827-1832.
69. +-dependent isoform of 11β-hydroxysteroid dehydrogenase: cloning and characterization of cDNA from sheep kidney. J Biol Chem 269:25959-25962.
70. Leenders F, Adamski J, Husen B, Thole HH, Jungblut PW (1994). Molecular cloning and amino acid sequence of the porcine 17 beta-estradiol dehydrogenase. Eur J Biochem 222:221-227.
71. Pelletier G, Luu-The V, Labrie F (1995). Immunocytochemicl localization of type 1 17β-hydroxysteroid dehydrogenase in the rat brain. Brain Res 704:233-239.
72. Mensah-Nyagan AM, Feuilloley M, Do-Rego JL, Marcual A, Lange C, Tonon MC, Pelletier G, Vaudry H (1996). Localization of 17β-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. USA. 93:1423-1428.
73. Evans SV (1993). SETOR: hardware lighted three-dimensional solid model representation of macromolecules. J Mol Graphics 11: 134-138.
74. Luu-The V, Zhang Y, Poirier D, Labrie F (1995). Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation-reduction and inhibition. J Steroid Biochem Mol Biol 55:581-587.